Invention Grant
- Patent Title: Heteroaryl carboxamide derivatives
- Patent Title (中): 杂芳基甲酰胺衍生物
-
Application No.: US12484552Application Date: 2009-06-15
-
Publication No.: US08227613B2Publication Date: 2012-07-24
- Inventor: Jean-Michel Adam , Johannes Aebi , Alfred Binggeli , Luke Green , Guido Hartmann , Hans P. Maerki , Patrizio Mattei , Fabienne Ricklin , Olivier Roche
- Applicant: Jean-Michel Adam , Johannes Aebi , Alfred Binggeli , Luke Green , Guido Hartmann , Hans P. Maerki , Patrizio Mattei , Fabienne Ricklin , Olivier Roche
- Applicant Address: US NJ Nutley
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Nutley
- Agent George W. Johnston; Patricia S. Rocha-Tramaloni; Gene J. Yao
- Priority: EP08158499 20080618
- Main IPC: C07D211/68
- IPC: C07D211/68 ; A61K31/445
Abstract:
The invention is concerned with novel heteroaryl carboxamide derivatives of formula (I), wherein m, X, Y, R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor, CCR-5 receptor and/or CCR-3 receptor and can be used as medicaments.
Public/Granted literature
- US20090318467A1 NOVEL HETEROARYL CARBOXAMIDE DERIVATIVES Public/Granted day:2009-12-24
Information query
